Standard care plus IV tranexamic acid vs placebo or usual care
Maternal blood loss of 500 mL or greater · women with primary postpartum haemorrhage following vaginal or caesarean birth
Standard care plus IV tranexamic acid may leads to lower blood loss 500 mL or more after randomisation compared with placebo or standard care alone (low certainty).
1 finding from 1 review
- Antifibrinolytic drugs for treating primary postpartum haemorrhage 2018 · Cochrane Headline outcomes onlyRR 0.5 [0.27, 0.93]1 study · 151 participantsLow